3rd Edition of Global Meeting on Cancer Research and Therapy (GMCRT-2026)

  09 Jul 2026 - 10 Jul 2026

   Boston, USA

conference-img

3rd Edition of Global Meeting on Cancer Research and Therapy (GMCRT-2026)

09 Jul 2026

 - 

10 Jul 2026

Boston, USA



Premier global event bringing together oncologists, oncosurgeons, researchers, and clinicians to discuss breakthroughs in oncological issues and oncological healthcare.

The event showcases cutting-edge oncology research, novel therapies, interactive sessions, keynote talks, and networking with global leaders advancing the diagnosis, treatment, and care of oncological diseases.

International Conference on Oncology (ICO) - Las Vegas, USA

On: 24 Nov 2025

-

25 Nov 2025


International Conference on Tumor Immunology and Immunotherapy (ICTII)- Las Vegas

On: 24 Nov 2025

-

25 Nov 2025


International Conference on Radiation Oncology (ICORAO-25)

On: 26 Nov 2025

-

27 Nov 2025


International Conference on Clinical Gynecology and Women Oncology (ICCGWO-25)

On: 28 Nov 2025

-

29 Nov 2025


5th International Conference on Cardiology

On: 28 Nov 2025

-

29 Nov 2025


International Conference on Oncology (ICO) - Las Vegas, USA

On: 24 Nov 2025

-

25 Nov 2025


International Conference on Tumor Immunology and Immunotherapy (ICTII)- Las Vegas

On: 24 Nov 2025

-

25 Nov 2025


International Conference on Radiation Oncology (ICORAO-25)

On: 26 Nov 2025

-

27 Nov 2025


International Conference on Clinical Gynecology and Women Oncology (ICCGWO-25)

On: 28 Nov 2025

-

29 Nov 2025


5th International Conference on Cardiology

On: 28 Nov 2025

-

29 Nov 2025



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

2.

An Intimate Life of Medical Innovation and Charity.

3.

Decoding calcifications in breast cancer: Towards personalized medicine

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot